CBE Ollis Lecture: Peter Zandstra (Univ. of British Columbia)
CBE Ollis Lecture: Peter Zandstra (Univ. of British Columbia)
Abstract Engineering Immune System Development Engineered T cells are at the leading edge of clinical cell therapy. T cell therapies have had a remarkable impact on patient care for a subset of hematological malignancies. This foundation has motivated the development of off-the-shelf engineered cell therapies for a broad range of devastating indications. Achieving this vision…